Ngaba Kukho Ubudlelwane Phakathi kwePSA kunye neNqanaba leKholesterol yakho?

Ukunciphisa i-cholesterol yakho kunye namanqanaba e-triglyceride akulungele ukunciphisa ingozi yesifo senhliziyo, kunokuncedisa ukunciphisa amanqanaba akho aphezulu ePSA. I-PSA, ifumaneka kwi-antigen ethile ye-prostiteni, impawu eziqhelekileyo ezisetyenziselwa ukulinganisa impilo ye-prostate emadodeni-kwaye ingasetyenziselwa ukucacisa ukuba kukho umhlaza wesibeletho okanye ezinye iimeko zonyango ezibandakanya i-prostate.

Ukuphakama kwamanqanaba akho e-PSA kukuba, ukuphakamisa umngcipheko wakho kukuba nomhlaza wesifo seprotate okanye i-prostate ephakamileyo. Nangona kukho iziganeko apho amazinga e-PSA anokuba nomhlaza ophezulu kunye nomhlaza wesifo seprotate awukho khona, kusengcono ukuba amazinga e-PSA aphantsi kangangoko kunokwenzeka. Kukho izifundo ezimbalwa eziye zavela ukuba kukho ukulwa phakathi kwamanqanaba akho e-cholesterol kunye namazinga akho e-PSA.

Ubudlelwane Phakathi kweCholesterol kunye nePSA Levels

Ucwaningo oluthile kumadoda luboniswe ukuba, emva kokuqala unyango lwe- statin ukunciphisa amazinga e-cholesterol ye- LDL, amanqanaba e-PSA anciphisa phakathi kwe-4 no-40%. Olunye uphando lwacetyiswa ukuba yonke i-10% ye-cholesterol yehlelwe yi-statins, i-PSA yamanqanaba angama-1.6 ng / mL. Olu lwalamano lubonakala lubonakala luluntu kumhlophe, kodwa alukho amadoda amnyama. Kwamadoda amhlophe, ukwanda kwe-serum prostate serum antigen yayinxulumene namazinga okwanda kwe-cholesterol kunye namazinga e-LDL ye-cholesterol.

Nangona kunjalo, uphando aluzange lube nolwalamano phakathi kwe-PSA kunye ne-HDL ye-cholesterol okanye amanqanaba e-triglyceride.

Ngaba Unokunciphisa Iinqwelo Zakho ze-Cholesterol kwakhona Nciphisa amanqanaba akho e-PSA?

Ukususela ngoku, akukho ubungqina obaneleyo bokuseka ubudlelwane obucacileyo okanye intsingiselo phakathi kwamanqanaba ePSA aphakamileyo kunye namazinga aphezulu e-cholesterol.

Nangona kubonakala ukuba ukunciphisa amazinga e-cholesterol aphezulu kunokunciphisa amanqanaba e-PSA, okwamanje awaziwa ukuba luhlobo luni lwefuthe eliya kuba nalo mngcipheko wesifo somhlaza okanye isifo. Ukongezelela, awaziwa ukuba ukunciphisa izinga lakho le-lipid linciphisa umngcipheko wokuba nenye yeemeko zonyango - okanye ukuba eso sifo sikhona nangona i-PSA iyanciphisa amanqanaba e-cholesterol.

Izifundo ezihlolisisa ubudlelwane phakathi kwe-cholesterol kunye ne-PSA zisetyenziselwa umgangatho we-cholesterol. Ngoko ke, akunakunxulumana phakathi kwe-cholesterol kunye ne-PSA efuna ukuba uphando olongezelelweyo-kodwa ukusetyenziswa kweemimiselo zezempilo kwi-prostate. Iitatimins zinempahla ekhethekileyo - ngaphandle kokunciphisa iip lipids - eziquka ukunciphisa ukuvuvukala. Kuze kubekho uphando olongezelelweyo oluqhutyelwayo, alukwazi ngokucacileyo ukuba amazinga ephezulu e-cholesterol ahambelana namanqanaba aphakamileyo ePSA kunye nokuba olu buhlobo luthetha ukuthini.

Umthombo:

Hamilton RJ, Platz EA, Goldberg KC, Freedland SJ. Umbutho phakathi kwe-cholesterol kunye ne-PSA. J Urol 2008; 179: 721 ingqiqo 2094.

Zapata D, Howard LE, Allott EH et al. Ingaba i-PSA inxulumene ne-cholesterol ye-serum kwaye ngaba ulwalamano lwahluke phakathi kwamnyama nabamhlophe? Prostate 2015; 75: 1877-1885.

YuPeng L, YuXue Z, PengFei L, eta l. Amazinga e-Cholesterol egazini kunye nomngcipheko womhlaza wesifo seprotate: uhlalutyo lwe-meta-uphando lwezifundo ezi-14. I-Cancer Epidemiol Biomarkers Ngo-2015; 24: 1086-1093.

Hamilton RJ, Goldberg KC, Platz EA, et al. Iimpembelelo zemithi ye-statin kwi-prostate-specific antigen levels. I-Natl Cancer Inst 2008: 100: 1511-1518.